Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Becton, Dickinson And Company (BDX) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Becton, Dickinson And Company (BDX) lobbying for?
Summary of lobbying data for Becton, Dickinson And Company:
– Lobbying firms hired: King & Spalding Llp, Baker & Hostetler Llp, Tarplin, Llc, Downs & Young
– General issues they lobbied on: Taxation/Internal Revenue Code, Budget/Appropriations, Medicare/Medicaid, Health Issues
– Specific issues they lobbied on: diagnostics, H.R. 2471, health IT, Operation Warp Speed, Consolidated Appropriations Act, including reimbursement issues, America COMPETES Act S. 4348, opioid diversion, medical technology regulation, ESRD, Consolidated Appropriations Act 2022 deficit reduction, COVID-19 testing, medication safety & drug diversion, including reimbursement and medical sterilization issues, reconciliation, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023, Syringes, H.R. 6833, H.R.2617 – Consolidated Appropriations Act, hazardous drug safety, artificial intelligence, H.R. 1319, American Rescue Plan of 2021 implementation S. 1260, Implementation of the American Rescue Plan, Regulatory and reimbursement policy issues related to federal healthcare programs, the Build Back Better Act H.R. 4521, Food and Drug Amendments of 2022 FDA related issues, pandemic preparedness, user fees, anti-microbial resistance, privacy, U.S. Innovation and Competition Act of 2021 H.R. 5376, Public Law 117-2 and federal funding for COVID testing; issues affecting manufacturer and direct supplier of medical products, VA procurement, coronavirus response, 2023 FDA related issues, NIH Funding, flow cytometry, Food and Drug Amendments of 2022 H.R.2617, including Medicare and Medicaid., tax reform implementation, cybersecurity, H.R. 5376, FDA Safety and Landmark Advancements Act H.R. 7667, 2023, the Inflation Reduction Act H.R. 4521, Unique Device Identifier, the Inflation Reduction Act tariff and trade policies, American Rescue Plan of 2021 implementation Medicare coverage and reimbursement, the Build Back Better Act tariff and trade policies, opioid safety
– Government agencies they lobbied: House of Representatives, Department of Health & Human Services (HHS), Senate, Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP)
One could infer that Becton, Dickinson And Company is lobbying on the issues related to healthcare policies and regulations, as well as government funding and trade policies, to protect its interests as a manufacturer and direct supplier of medical products. This could include issues related to Medicare and Medicaid coverage and reimbursement, access to federal healthcare programs, regulatory and reimbursement policies, pandemic preparedness, and anti-microbial resistance. Additionally, the company may be lobbying on issues related to tax reform, cybersecurity, and user fees to protect its financial interests.
